logo

FDA Calendar

Share
Company Name GW Pharmaceuticals PLC
Drug Name Epidiolex (NDA)
Event Name FDA decision on Epidiolex for treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Event Date 06/27/2018
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar